IRF8 and neoplasm: Despite a general loss of cross-presentation in Batf3–/– mice, cytotoxic T cells could still actively contribute to tumor surveillance through activation by nonclassical cross-presenting DCs and classical DC1s generated by Irf8 compensating for Batf3 deficiency (30, 48, 49).